Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Silvia Serrano-Huertas"'
Autor:
Alfredo Carrato, Manuel Benavides, Enrique Aranda, E. Macarena Rodríguez-Serrano, Elisa Conde, Carolina Blanco-Agudo, Lorena Crespo-Toro, María Laura García-Bermejo, Laura Salinas-Muñoz, Edurne Ramos-Muñoz, Reyes Ferreiro, Mercedes Rodríguez-Garrote, Bartomeu Massuti, Bruno Sainz, Pilar García Alfonso, Jose Carlos Martínez Ávila, Julie Earl, Silvia Serrano-Huertas
Publikováno v:
Cancers
Cancers, Vol 13, Iss 1710, p 1710 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Volume 13
Issue 7
Cancers, Vol 13, Iss 1710, p 1710 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Volume 13
Issue 7
© 2021 by the authors.
First-line treatment with regorafenib in frail metastatic colorectal cancer (mCRC) patients has shown some benefit. To accurately identify such patients before treatment, we studied blood biomarkers and primary tumor mole
First-line treatment with regorafenib in frail metastatic colorectal cancer (mCRC) patients has shown some benefit. To accurately identify such patients before treatment, we studied blood biomarkers and primary tumor mole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fbac1e1a6e39f8fe018137f57f95fc8
http://europepmc.org/articles/PMC8038427
http://europepmc.org/articles/PMC8038427
